期刊文献+

进展期胃底贲门癌患者转移阴性淋巴结数目对预后的影响 被引量:2

Impact of negative lymph node number on prognosis advanced cancer of cardiac and stomach fundus
原文传递
导出
摘要 目的探讨进展期胃底贲门癌镜检转移阴性淋巴结数目对预后的影响。方法对236例进展期胃底贲门癌患者施行D2根治术,根据镜检转移阴性淋巴结数目进行分组,分析转移阴性淋巴结数目与术后5年生存率、复发率间的关系。结果236例进展期胃底贲门癌患者术后5年生存率为37.5%。转移阴性淋巴结的数目与清扫淋巴结总数呈正相关(P〈0.05)。同一病期,转移阴性淋巴结的数目越多,术后5年生存率越高,差异具有统计学意义(P〈0.05)。线性回归预测,随着转移阴性淋巴结数目的增加,术后生存率可得到不同程度的提高,Ⅲ期和Ⅳ期的回归系数差异均具有统计学意义(均P〈0.05)。术后5年总体复发率为61.0%,Ⅲ期、Ⅳ期患者转移阴性淋巴结数目越多,术后复发率越低,总体差异均具有统计学意义(P〈0.05)。结论转移阴性淋巴结数目可反映淋巴结清扫的程度和预后。进展期胃底贲门癌患者在施行D2根治术时,应积极争取清扫足够的转移阴性淋巴结,以提高疗效,降低术后复发率。 Objective To analyze the impact of negative lymph node number on the prognosis of advanced cancer of the cardia and stomach fundus, Methods 236 patients with advanced cancer of the cardia and stomach fundus underwent D2 radical resection. 5-year survival rate and recurrence rate were followed up and the relationships of lymph node ( LN ) number to 5-year survival rate and recurrence rate were analyzed respectively, according to LN count subgroups. Results The 5-year survival rate of the entire cohort was 37.5%. The number of metastasis negative LNs was positively correlated with the LNs examined ( P 〈 O. 05 ). For the cancer at the same stage, the higher the number of metastasis negative LNs the higher the 5-year survival rate ( P 〈 O. 05 ). Linear correlation analysis showed that along with the increase of the number of negative LNs the post-operative survival rate increased. In the cancers at the stages Ⅲ and Ⅳ, the 5-year survival rate increased by 6.09% and 7.65% respectively compared to the predicted values ( P = O. 013 and P =0. 035). The overall recurrence rate was 61.0% within 5 years after surgery. For the cancers at the stages Ⅲ and Ⅳ, the more the number of negative LNs the higher the 5-year survival rates ( P 〈 O. 05 ). In the cancers at the stages Ⅲ and Ⅳ there were significant differences in the recurrence rates among the subgroups with different numbers of negative LNs ( all P 〈 O. 002 ). Conclusion Number of negative LNs has a close relation with stage-based survival prediction. Dissection of sufficient lymph nodes in the procedure of D2 dissection should be recommended so as to improve the long-term therapeutic effects and reduce the recurrence rate.
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第19期1327-1330,共4页 National Medical Journal of China
关键词 胃肿瘤 淋巴结 肿瘤转移 淋巴结切除术 预后 Stomach neoplasms Lymph nodes Neoplasm metastasis Lymph node excision Prognosis
  • 相关文献

参考文献11

  • 1Devesa SS, Fraumeni JJ. The rising incidence of gastric cardia cancer. J Natl Cancer Inst, 1999,9:747-749.
  • 2Piso P, Wemer U, Lang H, et al. Proximal versus distal gastric carcinoma: what are the differences? Ann Surg Oncol, 2000,7: 520-525.
  • 3Park JM, Ryu WS, Kim JH, et al. Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection. Cancer Res Treat, 2006, 38: 13-18.
  • 4Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after 132 resection for gastric cancer: analysis of a large European mono-institutional experience. Ann Surg Oncol, 2003,10: 1077- 1085.
  • 5Lee E, Chae Y, Kim I, et al. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer, 2002,94:2867-2873.
  • 6Hyung W J, Lee JH, Choi SH, et al. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer, Ann Surg Oncol,2002,9:562-567.
  • 7Kattan MW, Karpeh MS, Mazumdar M, et al. Postoperative nomogram for disease-specific survival after an R0 resection for gastric cancer. J Clin Oncol,2003,21:3647-3650.
  • 8Schwartz, RE, Smith D. Clinical impact of lymphadenectomy extent in respectable gastric cancer of advanced stage. Ann Surg Oncol,2007,14:317-328.
  • 9Wu CW, Lo SS, Shen KH, et al. Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg,2003 ,27 :153-158.
  • 10Kodera Y, Ito S, Yamamura Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol,2003,10:898-902.

同被引文献11

引证文献2

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部